Diagnostic endoscopic procedures on the lower gastrointestinal tract
Ask the expert
The report presents a summary of reimbursement situation for diagnostic endoscopic procedures on the lower gastrointestinal tract for benign and malignant diseases in outpatient settings.
The following procedures will be considered:
The report will consider both stand-alone diagnostic procedures and in combination with biopsy of lesions.
The only reimbursement within public / statutory health insurance systems is considered.
Report includes essential information about reimbursement and national funding, including:
- Brief overview of reimbursement system for medical devices
- Procedure coding for technology
- Diagnosis coding
- Payment mechanism for technology
- Reimbursement tariffs for technology
- Restrictions in indications or scenarios for use of technology
- Policy considerations by payers and policy-makers about technology
Reimbursement information is provided for the following geographies:
- England (UK)
It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.
Manufacturers of endoscope equipment for the lower gastrointestinal tract include:
- Alltion (Fiber-CS)
- Aohua Ednoscopy (FHD-CL, VCC)
- EndoChoice (Fuse)
- Endomed Systems (Duo, Combo-3)
- Fujifilm Holdings Corporation (Eluxeo EC, RU, EI, EC)
- Huger Endoscopy System (CVE)
- Interscope (EndoRotor)
- KARL STORZ GmbH & Co. KG (Silver Scope, Tele Pack X GI, Troidl Silver Scope)
- Olympus (EVIS EXERA-CF, PCF, SIF, CHF-V)
- Pentax medical (RetroView, MagniView EC, G‑EYE, FCP‑9P)
- SonoScape (ES-500, EC-430, EC-330)
Table of content is not available at the moment. Report is still ongoing.
The Danish Health Authority (Sundhedsstyrelsen) updates the Health Care Classification System (Sundheds-væsenets Klassifikations System, SKS) quarterly. It publishes the results on its website two weeks before the implementation, while the files with the changes are sent to the hospital systems. Most of the newly introduced procedure codes concern the gastrointestinal field.Read more
In January 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, has published Bulletins 0174 and 0071 with changes to be implemented not later than May 01, 2021. Five new procedure codes related to the areas of men's health, robotic surgery, endoscopy, and orthopedics, as well as three new diagnostic codes, were introduced.Read more
In November 2020, the Clinical Coding and Schedule Development (CCSD) group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, has published Bulletins 0173 and 0070 with changes to be implemented not later than February 01, 2021. Three new procedure codes were introduced, related to robotic laparoscopy in gynecology, brachytherapy in prostate tumor, and autologous bone marrow aspirate concentrate (BMAC) for osteochondral defects of the knee. Also, four codes for diagnostic tests were added.Read more
In Sensible Care projects, the Dutch Healthcare Institute, together with other parties, is investigating the possibilities for improving care pathways for patients. As of early November 2020, there are 30 ongoing projects, including two projects for assessing knee and hip osteoarthritis treatment and medicines for castration-refractory prostate carcinoma at the final evaluation phase.Read more
In late September 2020, the Austrian version of the DRG system (LKF) 2021 model with the relevant supplementary documents was published in Austria. For 2021, the main changes include the addition of sixteen new procedure codes and the introduction of two new procedure codes for billing in the day-case settings, update of cases flat rates, and adjustments of the cases daily component calculation.Read more